Targeting outpatient drug safety: Recommendations of the dutch HARM-Wrestling task force

Drug Safety

Volumn 35, Issue 3, 2012, Pages 245-259

  Warlé Van Herwaarden, Margaretha F ^a   Kramers, Cees ^a   Sturkenboom, Miriam C ^b   Van Den Bemt, Patricia M L A ^b,c   De Smet, Peter A G M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Bradycardia; CNS; Constipation; Corticosteroids; Diuretics; Fracture; Gastrointestinal haemorrhage; Haemorrhage; Heart failure; Hospitalisation; Hyperglycaemia; Hyperkalaemia; Hypoglycaemia; Hypokalaemia; Hyponatraemia; Nonsteroidal anti inflammatories; Opioid analgesics; Platelet aggregation inhibitors; Renal failure; Renin angiotensin system; Vitamin K antagonists.

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN ANTAGONIST; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; CARDIOVASCULAR AGENT; CENTRAL NERVOUS SYSTEM AGENTS; CLOPIDOGREL; CORTICOSTEROID; DIGOXIN; DIURETIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE DERIVATIVE; PRASUGREL; SEROTONIN UPTAKE INHIBITOR; SOTALOL; SPIRONOLACTONE;

ARTICLE; BLEEDING; BRADYCARDIA; COMPUTER SYSTEM; CONSTIPATION; CORTICOSTEROID INDUCED OSTEOPOROSIS; DIABETES MELLITUS; DRUG SAFETY; ELECTROLYTE DISTURBANCE; EVIDENCE BASED PRACTICE; FEASIBILITY STUDY; FRACTURE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEART FAILURE; HOSPITAL ADMISSION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; INCIDENCE; KIDNEY FAILURE; NETHERLANDS; OUTPATIENT; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK FACTOR; RISK REDUCTION;

ADVERSE DRUG REACTION REPORTING SYSTEMS; ADVISORY COMMITTEES; DRUG TOXICITY; HOSPITALIZATION; HUMANS; NETHERLANDS; OUTPATIENTS; PHARMACEUTICAL PREPARATIONS; PRACTICE GUIDELINES AS TOPIC; PUBLIC HEALTH; RISK FACTORS;

EID: 84857145797     PISSN: 01145916     EISSN: 11791942     Source Type: Journal    
DOI: 10.2165/11596000-000000000-00000     Document Type: Article

References (41)

1. Beijer HJ, de Blaey CJ. Hospitalisations caused by adverse drug reactions (ADR): a meta analysis of observational studies. Pharm World Sci 2002 Apr; 24 (2): 46-54 (Pubitemid 34534816)
2. Sturkenboom MCJM, Dieleman JP. Ziekenhuisopnames door bijwerkingen van geneesmiddelen-een inventarisatie. Eindrapport. Rotterdam: Erasmus MC, 2006
3. van derHooftCS, SturkenboomMC, vanGrootheestK, et al. Adverse drug reaction-related hospitalisations: a nationwide study in The Netherlands. Drug Saf 2006; 29 (2): 161-8 (Pubitemid 43213889)
4. Hallas J, Harvald B, Gram LF, et al. Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990 Aug; 228 (2): 83-90 (Pubitemid 20257272)
5. Schumock GT, Thornton JP. Focusing on the preventability of adverse drug reactions. Hosp Pharm 1992 Jun; 27 (6): 538
6. Leendertse AJ, Egberts AC, Stoker LJ, et al. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med 2008 Sep 22; 168 (17): 1890-6
7. Van den Bemt PMLA, Egberts ACG, Leendertse A. Hospital Admissions Related to Medication (HARM). Een prospectief, multicenter onderzoek naar geneesmiddel gerelateerde ziekenhuisopnames. Eindrapport. Utrecht: Division of Pharmacoepidemiology & Pharmacotherapy, Utrecht Institute for Pharmaceutical Sciences, 2006
8. Kramer MS, Leventhal JM, Hutchinson TA, et al. An algorithm for the operational assessment of adverse drug reactions: I. Background, description, and instructions for use. JAMA 1979 Aug 17; 242 (7): 623-32 (Pubitemid 9252462)
9. De Smet PAGM, Denneboom W, Kramers C, et al. A composite screening tool for medication reviews of outpatients: general issues with concrete examples. Drugs Aging 2007; 24 (9): 733-60 (Pubitemid 47378289)
10. Stricker BH, Psaty BM. Detection, verification, and quantification of adverse drug reactions. BMJ 2004 Jul 3; 329 (7456): 44-7 (Pubitemid 38870007)
11. Vandenbroucke JP. When are observational studies as credible as randomised trials? Lancet 2004 May 22; 363 (9422): 1728-31 (Pubitemid 38670333)
12. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008 Apr 26; 336 (7650): 924-6 (Pubitemid 351632017)
13. GRADE working group. The Grading of Recommendations Assessment, Development and Evaluation (short GRADE) Working Group [online]. Available from URL: http://www.gradeworkinggroup.org [Accessed 2010 Aug 16]
14. Guyatt GH, Cook DJ, Jaeschke R, et al. Grades of recommendation for antithrombotic agents: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th ed.). Chest 2008 Jun; 133 Suppl. 6: 123-31S (Pubitemid 351892964)
15. Warlé-Van Herwaarden MF, Kramers C, Sturkenboom MC, et al. Targeting outpatient drug safety: recommendations of the Dutch HARM-Wrestling Task Force. Den Haag: Koninklijke Nederlandse Maatschappij ter bevordering der Pharmacie, 2010 [online]. Available from URL: http://www.knmp.nl/downloads/ medicijnen-zorgverlening/med icatieveiligheid/harmwrestlingEnglishcopyrightKNMP. pdf/view [Accessed 2012 Jan 3]
16. Visser LE, Graatsma HH, Stricker BH. Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 2002 Feb; 53 (2): 183-8 (Pubitemid 34264273)
17. van der Linden CM, Kerskes MC, Bijl AM, et al. Represcription after adverse drug reaction in the elderly: a descriptive study. Arch Intern Med 2006 Aug 14; 166 (15): 1666-7 (Pubitemid 44232379)
18. Zhang M, Holman CD, Preen DB, et al. Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980-2003. Br J Clin Pharmacol 2007 Feb; 63 (2): 163-70 (Pubitemid 46072102)
19. Beyth RJ, Quinn LM, Landefeld CS. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998 Aug; 105 (2): 91-9 (Pubitemid 28405230)
20. Ansell J, Hirsh J, Poller L, et al. The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004 Sep; 126 Suppl. 3: 204-33S (Pubitemid 39297955)
21. Feenstra J, Heerdink ER, Grobbee DE, et al. Association of nonsteroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch InternMed 2002 Feb 11; 162 (3): 265-70 (Pubitemid 34127403)
22. Centraal Begeleidings Orgaan (CBO). Richtlijn: NSAIDgebruik en preventie van maagschade. 2003 [online]. Available from URL: http://www.cbo.nl/Downloads/ 259/richtlijnnsaid.pdf [Accessed 2012 Jan 3]
23. Raynor DK, Blenkinsopp A, Knapp P, et al. A systematic review of quantitative and qualitative research on the role and effectiveness of written information available to patients about individual medicines. Health Technol Assess 2007 Feb; 11 (5): iii, 1-160
24. Anonymous. HARM-WRESTLING: een voorstel van de Expertgroep Medicatieveiligheid m.b.t. concrete interventies die de extramurale medicatieveiligheid op korte termijn kunnen verbeteren. Den Haag: Ministerie van Volksgezondheid, Welzijn en Sport, 2009
25. Schneeweiss S,Hasford J, GottlerM, et al. Admissions caused by adverse drug events to internal medicine and emergency departments in hospitals: a longitudinal population-based study. Eur J Clin Pharmacol 2002 Jul; 58 (4): 285-91 (Pubitemid 34827858)
26. Howard RL, Avery AJ, Slavenburg S, et al. Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2007; 63: 136-47 (Pubitemid 46072098)
27. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004 Jul 3; 329 (7456): 15-9 (Pubitemid 38869995)
28. Buurma H, De Smet PAGM, Kruijtbosch M, et al. Disease and intolerability documentation in electronic patient records. Ann Pharmacother 2005 Oct; 39 (10): 1640-6 (Pubitemid 41393122)
29. Buurma H, Schalekamp T, Egberts ACG, et al. Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies. Ann Pharmacother 2007; 41 (12): 2024-31 (Pubitemid 350230572)
30. Ashcroft DM, Parker D. Development of the Pharmacy Safety Climate Questionnaire: a principal components analysis. Qual Saf Health Care 2009 Feb; 18 (1): 28-31
31. Ashcroft DM, Morecroft C, Parker D, et al. Safety culture assessment in community pharmacy: development, face validity, and feasibility of the Manchester Patient Safety Assessment Framework. Qual Saf Health Care 2005 Dec; 14 (6): 417-21 (Pubitemid 41820066)
32. De Smet PAGM, Dautzenberg M. Repeat prescribing: scale, problems and quality management in ambulatory care patients. Drugs 2004; 64: 1779-800 (Pubitemid 39215189)
33. Kuijpers MA, van Marum RJ, Egberts AC, et al. Relationship between polypharmacy and underprescribing. Br J Clin Pharmacol 2008 Jan; 65 (1): 130-3 (Pubitemid 350265160)
34. Denneboom W, Dautzenberg M, Grol RP, et al. Analysis of polypharmacy in older patients in primary care using a multidisciplinary expert panel. Br J Gen Pract 2006; 56: 504-10 (Pubitemid 43984467)
35. Cote GA, Rice JP, Bulsiewicz W, et al. Use of physician education and computer alert to improve targeted use of gastroprotection among NSAID users. Am J Gastroenterol 2008May; 103 (5): 1097-103 (Pubitemid 351678001)
36. Palmer BF. Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system. N Engl J Med 2004 Aug 5; 351 (6): 585-92
37. Reardon LC, Macpherson DS. Hyperkalemia in outpatients using angiotensin-converting enzyme inhibitors. How much should we worry? Arch Intern Med 1998 Jan 12; 158 (1): 26-32 (Pubitemid 28070442)
38. Verhave JC, Kramers C, Wetzels JFM. Nauwkeurige indruk van de nierfunctie. Nieuwe formule leidt tot betere schattingen. Pharm Weekbl 2007; 142 (40): 18-21, 56
39. Centraal Begeleidings Orgaan (CBO). Osteoporose Tweede herziene richtlijn. Utrecht: Kwaliteitsinstituut voor de Gezondheidszorg CBO, 2002
40. De Smet PA. Hospital admissions related to medications and implementing guidelines. Arch InternMed 2009 Apr 27; 169 (8): 810-1
41. Fugh-Berman A, Ahari S. Following the script: how drug reps make friends and influence doctors. PLoS Med 2007 Apr; 4 (4): e150